About Us
Molecular Gate
Dr. Aleksandr Perevedentsev
CTO & co-founder
Aleksandr Perevedentsev, is a founding partner, co-inventor of the patent and CTO of MG. Doctor in Experimental Physics from Imperial College London. Aleksandr and works on the company’s technical development and its research activities. His academic background includes extensive international research experience encompassing positions and fellowships in the UK, Switzerland, Germany and Spain, as well as numerous collaborations with international research centers and industrial partners.
Prof. Mariano Campoy-Quiles
Consultant & co-founder
Mariano Campoy-Quiles is a founding partner, co-inventor of the patent and acts as scientific advisor at MG. Doctor in Experimental Physics from Imperial College London, he is ranked in the top 2% of scientific researchers in the world (Stanford ranking). He currently leads a team of 12-15 people at ICMAB-CSIC distributed in two fully equipped laboratories dedicated to research in organic semiconductors.
BeAble Innvierte Kets Fund
Managed by BeAble Capital, it is the first and only private and independent industrial high technology fund in Spain that invests in Deep Tech technologies, its priority areas of interest being: Advanced Materials, Micro and Nanoelectronics, Photonics, Nanotechnology, Industrial Biotechnology and Biotechnology Technologies. the communication. As a completely independent fund, BeAble Capital is not linked to any research center or university, and getting its advice and support is a symbol of prestige for any technology company. The maximum size of the fund is 34.6 M € and it is participated, among other partners, by the European Investment Fund, Innvierte Economía Sostenible SICC SME, S.A. or FONDICO Global, FCR. BeAble Capital has acted as Molecular Gate’s protomor, trusting in the project and being part of it since the company was founded, investing, to date, 260,000 € in the development of the company. BeAble Capital has the capacity to invest up to 3M € per company, which reduces the financial risk of the project. In addition, it puts its extensive network of contacts within the financial sector at the service of Molecular Gate and represents a seal of guarantee for the project that will be able to channel the entry of institutional and professional investors in the future, both nationally and internationally.
ICMAB
The Institute of Materials Science of Barcelona (ICMAB-CSIC) is a multidisciplinary research center focused on cutting-edge research in functional advanced materials in the fields of energy, electronics, and nanomedicine. With over three decades of existence, ICMAB continues to generate knowledge and transfer it to society and industry. Additionally, it is part of the Barcelona Nanocluster in Bellaterra (BNC-b), which promotes nanoscience and nanotechnology.
Mr. Jose Moncayo
CEO
Jose Moncayo is CEO of the company, an Industrial Engineer from the UPC of Barcelona, who has developed his professional career in the FMCG and Pharma sectors for 30 years in multinational environments, including international business responsibilities for more than 10 years as export commercial director.
Dr. Michela Prete
Research Scientist
Holds a PhD in Engineering Science from the University of Southern Denmark, specializing in emerging photovoltaics. With extensive experience in organic electronic materials, fabrication upscaling, and product design, she brings a unique blend of academic rigor and industrial insight to her role. Michela’s international background, including education in Italy, Denmark and a visiting scholarship in the USA, enriches her work. Her research focuses on slot-die coating and printing of organic semiconductor materials.
With a wide network of collaborators and a dedication to innovation, Michela drives Molecular Gate SL’s pursuit of cutting-edge technology.
Road Map
Foundation
CSIC Patent BeAble in
Setting up the Company
Product Finalization
CEO Hiring
Financials 2nd round
New Post Doc Researcher
Industrial testing
Printing & compliance tests
Financials 3rd Round
First clients & Sales Q4